Utility of B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide in evaluation of respiratory failure in critically III patients

Chest

Volumn 128, Issue 1, 2005, Pages 288-295

  Jefic, Dane ^a,b   Lee, John W ^a   Jefic, Dijana ^a   Savoy Moore, Ruth T ^a   Rosman, Howard S ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Accuracy; B type natriuretic peptide; Contractile dysfunction; Critically ill; N terminal pro B type natriuretic peptide; Natriuretic peptide; Respiratory failure; Swan Ganz catheter; Wedge pressure

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; UNCLASSIFIED DRUG;

ACCURACY; ADULT; AGED; AREA UNDER THE CURVE; ARTERY CATHETERIZATION; ARTICLE; CLINICAL ARTICLE; CRITICAL ILLNESS; DISEASE ASSOCIATION; FEMALE; HEART DISEASE; HEART FAILURE; HEART INDEX; HEART STROKE VOLUME; HEMODYNAMICS; HUMAN; LUNG ARTERY; LUNG WEDGE PRESSURE; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY FAILURE; SURVIVAL;

EID: 22244477749     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.128.1.288     Document Type: Article

References (37)

1. Troughton RW, Frampton CM, Yandle TG, et al. Treatment of heart failure guided by plasma amino terminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000; 355:1126-1130
2. Richards AM, Lainchbury JG, Nicholls MG, et al. BNP in hormone-guided treatment of heart failure. Trends Endocrinol Metab 2002; 13:151-155
3. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347:161-167
4. Hobbs FD, Davis RC, Roalfe AK, et al. Reliability of NTpro-BNP assay in diagnosis of heart failure: cohort study in representative and high risk community populations. BMJ 2002; 324:1498-1500
5. Hammerer-Lercher A, Neubauer E, Muller S, et al. Head to head comparison of NTproBNP, BNP and NTproANP in diagnosing left ventricular dysfunction. Clin Chim Acta 2001; 310:193-197
6. Mair J, Hammerer-Lercher A, Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med 2001; 39:571-588
7. Bettencourt P. NT-proBNP and BNP: biomarkers for heart failure management. Eur J Heart Fail 2004; 6:359-363
8. Yeo KT, Wu AH, Apple FS, et al. Multicenter evaluation of the Roche NTproBNP assay and comparison to the Biosite Triage BNP assay. Clin Chim Acta 2003; 338:107-115
9. Kazanegra R, Chen V, Garcia A, et al. A rapid test for b-type natriuretic peptide (BNP) correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. J Card Fail 2001; 7:21-29
10. Morrison LK, Harrison A, Krishnaswamy P, et al. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 2002; 39:202-209
11. Bhala V, Maisel AS, Bhala MA. Evolution of B-type natriuretic peptide in evaluation of intensive care unit shock. Crit Cure Med 2004; 32:1787-1789
12. Maeder M, Ammann P, Rickli H, et al. Elevation of B-type natriuretic peptide levels in acute respiratory distress syndrome. Swiss Med Wkly 2003; 133:515-518
13. Tung RH, Garcia C, Morss AM, et al. Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock. Crit Care Med 2004; 32:1643-1647
14. Ando T, Ogawa K, Yamaki K, et al. Plasma concentrations of atrial, brain and C-type natriuretic peptides and endothelin-1 in patients with chronic respiratory diseases. Chest 1996; 110:462-468
15. Berendes E, Van Aken H, Raufhake C, et al. Differential secretion of atrial and brain natriuretic peptide in critically ill patients. Anesth Analg 2001; 93:676-682
16. Lang CC, Coutie WJ, Struthers AD, et al. Elevated levels of BNP in acute hypoxaemic chronic obstructive pulmonary disease. Clin Sci (Lond) 1992; 83:529-533
17. Hopkins WE, Chen Z, Fukagawa NK, et al. Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease. Circulation 2004; 109:2872-2877
18. Parker MM, Shelhamer JH, Bacharach SL, et al. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984; 100:483-490
19. Price S, Anning PB, Mitchell JA, et al. Myocardial dysfunction in sepsis: mechanisms and therapeutic implications. Eur Heart J 1999; 20:715-724
20. McCollough PM, Sandberg KR. B-Type natriuretic peptide and renal disease. Heart Fail Rev 2003; 8:355-358
21. Paul L Marino. The ICU book. 2nd ed. Baltimore, MD: Williams and Wilkins, 1998; 160-161
22. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41
23. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13:818-829
24. Dixon WJ, Massey FJ. Introduction to statistical analysis. 3rd ed. New York, NY: McGraw-Hill, 1969; 328,500
25. McLean AS, Tang B, Nalos M, et al. Increased B-type natriuretic peptide (BNP) level is a strong predictor for cardiac dysfunction in intensive care unit patients. Anaesth Intensive Care 2003; 31:21-27
26. Witthaut R, Busch C, Fraunberger P, et al. Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med 2003; 29:1696-1702
27. Pilz G, Appel R, McGinn P. Calculation of the left ventricular stroke work index. Crit Care Med 1993; 21:1248-1249
28. Seino Y, Ogawa A, Yamashita T, et al. Application of NTproBNP and BNP measurements in cardiac care: a more discerning marker for the detection and evaluation of heart failure. Eur J Heart Fail 2004; 6:295-300
29. McLean AS, Huang SJ, Nalos M, et al. The confounding effects of age, gender, serum creatinine, and electrolyte concentrations on plasma B-type natriuretic peptide concentrations in critically ill patients. Grit Care Med 2003; 31:2611-2618
30. Raymond I, Groenning BA, Hildebrandt PR, et al. The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart 2003; 89:745-751
31. Luchner A, Hengstenberg C, Lowel H, et al. N-terminal pro-brain natriuretic peptide after myocardial infarction: a marker of cardio-renal function. Hypertension 2002; 39:99-104
32. DeLemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001; 345:1014-1021
33. Omland T, Aakwag A, Bonarjee WS, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Circulation 1996; 93:1963-1969
34. Kucher N, Printzen G, Doernhoefer G, et al. Low pro-brain natriuretic peptide levels predict benign clinical outcome in acute pulmonary embolism. Circulation 2003; 107:1576-1578
35. Berger R, Huelsman M, Strecker K, et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 2002; 105:2392-2397
36. Harrison A, Morrison LK, Krishnaswamy P, et al. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med 2002; 39:131-138
37. James SK, Lindahl B, Siegbahn A, et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a global utilization of strategies to open occluded arteries (GUSTO)-IV substudy. Circulation 2003; 108:275-281